Hedge fund objects DuPont’s $5.8 bln bid for Danisco: report – International Business Times
By Dr. Matthew Watson
 New York Times | Hedge fund objects DuPont's $5.8 bln bid for Danisco: report International Business Times DuPont said the combination would create a world leader in industrial biotechnology. The offer represented a 25 percent premium to Danisco's closing share ... Dupont eyeing HubBoston Herald Danisco Board Accepts DuPont OfferFood Ingredients First (press release) Hedge fund joins opposition to DuPont's Danisco bidBaltimore Sun |
Uncategorized
Comments Off on Hedge fund objects DuPont’s $5.8 bln bid for Danisco: report – International Business Times |
February 12th, 2011
This author published 5472 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research